In China,lung cancer is a primary cancer type with high incidence and mortality.Risk factors for lung cancer include tobacco use,family history,radiation exposure,and the presence of chronic lung diseases.Most early-stage non-small cell lung cancer(NSCLC)patients miss the optimal timing for ...
Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer As one of the first studies testing perioperative anti-PD-(L)1 antibodies in resectable non-small-cell lung cancer (NSCLC), NADIM now confirms, in its final repo...
The third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) established a new standard for EGFR mutation positive non-small cell lung cancer (NSCLC) treatment. Brain metastases (BMS) are common in NSCLCs with poor prognosis, and patients with BMS who carry uncomm...
et al. Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification. BMC Pulm Med 23, 240 (2023). https://doi.org/10.1186/s12890-023-02482-9 Download citation Received14 January 2023 Accepted16 May...
Agents targeting programmed death-1 receptor (PD-1) and its ligand (PD-L1) are showing promising results in non-small-cell lung cancer (NSCLC). It is unknown whether PD-1/PD-L1 are differently expressed in oncogene-addicted NSCLC. We analysed a cohort of
Non-small cell lung cancer (NSCLC) accounts for more than 85% of newly diagnosed lung cancers.1 Nearly 40% of patients with NSCLC present with metastatic disease.2 Chemotherapy for advanced stage NSCLC provides only modest improvement in the overall survival.3, 4 Addition of bevacizumab, an ...
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the preferential options for advanced non-small cell lung cancer (NSCLC) patients harboring EGFR mutations. Osimertinib is a potent irreversible third-generation EGFR-TKI targeti
Non-Small Cell Lung Cancer (NSCLC) > All Subspecialties More News Stereotactic Radiosurgery/TKIs Improves CNS Outcomes in EGFR/ALK+ NSCLC Russ Conroy October 11th 2024 Patients with non–small cell lung cancer and larger brain metastases may benefit most from the addition of up-front stereotactic...
Summary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiation therapy. Credit: Emily Sterbis, MD, Interventional Radiology Resident at the University of Colorado A study published in the January issue ofThe Jou...
Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era et al.Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era[J].Clin Lung Can-cer,... JW Riess,S ...